Cargando…
Carbamazepine-associated Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome
Drug reaction with eosinophilia and systemic symptoms syndrome is a severe type IV (delayed T-cell-dependent reaction) hypersensitivity reaction, characterized by fever, mucocutaneous eruptions, eosinophilia, and systemic inflammatory involvement. It usually begins a few weeks after the exposure to...
Autores principales: | Sharma, Ankush, Joshi, Ekta, Gupta, Nitin, Joshi, Monika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276952/ https://www.ncbi.nlm.nih.gov/pubmed/34316309 http://dx.doi.org/10.4103/jpn.JPN_126_15 |
Ejemplares similares
-
Drug reaction with eosinophilia and systemic symptoms syndrome associated with Nitrofurantoin
por: Singh, Jitendra, et al.
Publicado: (2016) -
Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) induced by carbamazepine: a case report and literature review
por: EL Omairi, Nissrine, et al.
Publicado: (2014) -
Successful use of carbamazepine in a patient with drug rash with eosinophilia and systemic symptoms
por: Bixby, Alexandra L., et al.
Publicado: (2019) -
Alectinib-associated drug reaction with eosinophilia and systemic symptoms syndrome
por: Farooq, Sahira, et al.
Publicado: (2020) -
Apremilast-associated drug reaction with eosinophilia and systemic symptoms
por: Chapman, Stephanie, et al.
Publicado: (2020)